Publications

  1. Oria VO, Lopatta P, Schmitz T, Preca BT, Nyström A, Conrad C, Bartsch JW, Kulemann B, Hoeppner J, Maurer J, Bronsert P, Schilling O. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma. Mol Oncol. 2018 Dec 17. doi: 10.1002/1878-0261.12426.
  2. Hillebrand LE, Wickberg SM, Gomez-Auli A, Follo M, Maurer J, Busch H, Boerries M, Reinheckel T. MMP14 empowers tumor-initiating breast cancer cells under hypoxic nutrient-depleted conditions. FASEB J. 2018 Dec 6:fj201801127R. doi: 10.1096/fj.201801127R. [Epub ahead of print]
  3. Seidl, M, Bader M, Vaihinger A, Wellner UF, Todorova R, Herde B, Schrenk K, Maurer J, Schilling O, Erbes T, Fisch P, Pfeiffer J, Hoffmann L, Franke K, Werner M and Bronsert P. Morphology of Immunomodulation in Breast Cancer Tumor Draining Lymph Nodes Depends on Stage and Intrinsic Subtype. Scientific Reports. 2018;8(1):5321.
  4. Jolly MK, Preca B, Tripathi SC, Jia D, George JT, Hanash SM, Brabletz T,   Stemmler MP, Maurer J and Levine H. Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer. APL Bioengineering 2, 031908 (2018); doi.org/10.1063/1.5024874, Published Online: 22 August 2018  Accepted: July 2018
  5. Metzger E, Stepputtis SS, Strietz J, Preca BT, Urban S, Willmann D, Allen A, Zenk F, Iovino N, Bronsert P, Proske A, Follo M, Boerries M, Stickeler E, Xu J, Wallace MB, Stafford J, Kanouni T, Maurer J and Schüle R. KDM4 inhibition targets breast cancer stem cells. Cancer Research (2017), in press
  6. Preca BT, Bajdak K, Mock K, Lehmann W, Sundararajan V, Bronsert P, Matzge-Ogi A, Orian-Rousseau V, Brabletz S, Brabletz T, Maurer J, Stemmler MP. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer. Oncotarget. 2017 Feb 14;8(7):11530-11543. doi: 10.18632/oncotarget.14563.
  7. Enderle-Ammour K; Bader M; Ahrens TD; Franke KU; Timme S; Csanadi A; Hoeppner J; Kulemann B; Maurer J; Reiss CP; Schilling O; Keck T; Brabletz T; Stickeler E; Werner M; Wellner UF; Bronsert P. Form Follows Function - Morphological and Immunohistological Insights Into EMT Characteristics of Tumorbuds. Tumour Biol. 2017 May;39(5):1010428317705501. doi: 10.1177/1010428317705501.
  8. Allam A, Thomsen AR, Gothwal M, Saha D, Maurer J, Brunner TB. Pancreatic stellate cells in pancreatic cancer: In focus. Pancreatology. 2017 May 27. pii: S1424-3903(17)30485-4. doi: 10.1016/j.pan.2017.05.390. [Epub ahead of print] Review.
  9. Strietz J, Stepputtis SS, Preca BT, Vannier C, Kim MM, Castro DJ, Au Q, Boerries M, Busch H, Aza-Blanc P, Heynen-Genel S, Bronsert P, Kuster B, Stickeler E, Brabletz T, Oshima RG, Maurer J. ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer. Oncotarget. 2016 Dec 13;7(50):83278-83293. doi: 10.18632/oncotarget.13086.
  10. Preca BT, Bajdak K, Mock K, Sundararajan V, Pfannstiel J, Maurer J, Wellner U, Hopt UT, Brummer T, Brabletz S, et al. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. Int J Cancer. 2015 Dec 1;137(11):2566-77. doi: 10.1002/ijc.29642. Epub 2015 Jun 30.
  11. Castro DJ, Maurer J, Hebbard, L., & Oshima, R. G (2013). ROCK1 inhibition promotes the self-renewal of a novel mouse mammary cancer stem cell. Stem Cells (Dayton, Ohio), 31(1), 12-22. doi:10.1002/stem.1224
  12. Schulte JS, Lindner S, Bohrer A, Maurer J, DePreter K, Lefever S, Heukamp L, Schulte S, Molenaar J, Versteeg R, Thor T, Kunkele A, Vandesompele J, Speleman F, Schorle H, Eggert A, Schramm A. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells. Oncogene. 2013 Feb 21;32(8):1059-65. doi: 10.1038/onc.2012.106. Epub 2012 Apr 9.
  13. Lindner, S., Schulte, J. H., Bohrer, A., Maurer, J., DePreter, K., Lefever, S. & Schramm, A. (2011). Neuroblastoma develops from neural crest stem cells. Klinische Pädiatrie, 223(03),  A21.
  14. Steinmetz N.F., Maurer J., Sheng H., Bensussan A., Maricic I., Kumar V., Braciak T.A. Two Domains of Vimentin Are Expressed on the Surface of Lymph Node, Bone and Brain Metastatic Prostate Cancer Lines along with the Putative Stem Cell Marker Proteins CD44 and CD133. Cancers. 2011; 3(3):2870-2885.
  15. Murphy DA, Diaz B, Bromann PA, Tsai JH, Kawakami Y, Maurer J, Stewart RA, Izpisúa-Belmonte JC, Courtneidge SA (2011) A Src-Tks5 Pathway Is Required for Neural Crest Cell Migration during Embryonic Development. PLoS ONE 6(7): e22499. doi:10.1371/journal.pone.0022499
  16. Hebbard L, Maurer J, Amber M, Lesperance J, Hassell JA, Oshima RG, Terskikh A. (2010) MELK is Upregulated and Required in Mammary Tumor Initiating Cells In Vivo. Cancer Research 2010 Sep 22.
  17. Pajtler, K., Bohrer, A., Maurer, J., Schorle, H., Schramm, A., Eggert, A., Schulte, J. H., Production of Chick Embryo Extract for the Cultivation of Murine Neural Crest Stem Cells www.jove.com/details.stp doi: 10.3791/2380. J Vis Exp. 45 (2010).
  18. Curchoe CL and Maurer J, McKeown SJ, Cattarossi G, Cimadamore F, Nilbratt M, Snyder EY, Bronner-Fraser M, Terskikh AV. Early Acquisition of Neural Crest Competence During hESCs Neuralization, PLoS ONE: Research Article, published 09 Nov 201010.1371/journal.pone.0013890
  19. Bohrer, A. M., E. Mahlow, Maurer J, H. Schorle, A. Schramm, A. Eggert, and J. H. Schulte. "N-myc induces transformation of neural crest stem cells in vitro and in vivo." Klinische Pädiatrie 221, no. 03 (2009): A5.
  20. Schulte J, Bohrer A, Mahlow E, Maurer J, Schorle H, De Preter K, Vandesompele, J, Speleman F, Schlierf S, Pajtler K, Schramm A, Eggert A (2009). Modeling neuroblastomagenesis from neural crest stem cells in vitro and in vivo. Pediatric Blood &Cancer (Vol. 53, pp. 703–704). Hoboken: WILEY-LISS
  21. Maurer J, Nelson B, Ceceña G, Bajpai R, Mercola M, Terskikh A and Oshima RG. (2008) Contrasting expression of keratins in mouse and human embryonicstem cells. PlosOne; 3(10):e3451.
  22. Bohrer, A. M., Schramm, A., Maurer, J., Schorle, H., Astrahantseff, K., Eggert, A., & Schulte, J. H. (2008, May). JoMa1-a model to analyze neural crest stem cells in-vitro. In Klinische Pädiatrie (Vol. 220, No. 3, pp. 199-199
  23. Cabral-Teixeira J, Talsky K, Zhang L, Maurer J, Tsuda M, Chao YS, Prigozhina N, Price J, Snyder E, Mercola M, Ruoslahti E, West MD, Larocca D (2008) Targeting nanoparticle probes to differentiating stem cells. NSTI-Nanotech 2008, ISBN 978-1-4200-8504-4 (Vol.2, pp. 430-433)
  24. Maurer J, Fuchs S, Jäger R, Kurz B, Sommer L, Schorle H. (2007) Establishment and analysis of a neural crest stem cell line (JoMa1) using conditional transgeneis. Differentiation; 75(7): 580-591.
  25. Kretz M, Eckardt D, Krüger O, Kim JS, Maurer J, Theis M, Schorle H, Willecke K. (2006) Normal embryonic development and cardiac morphogenesis in mice with Wnt1-Cre mediated deletion of connexin43. Genesis; 44(6): 269-276.
  26. Hermann R, Poppe L, Pilbak S, Boden C, Maurer J, Weber S, Lerchl A. (2005) Predicted 3D-structure of melanopsin, the non-rod, non-cone photopigment of the mammalian circadian clock, from Djungarian hamsters (Phodopus sungorus). Neurosci Lett; 376(2): 76-80.
  27. Jäger R and Maurer J, Jacob A, Schorle H. (2004) Cell type-specific conditional regulation of the c-myc protooncogene by combining Cre/loxP recombination and tamoxifen-mediated activation. Genesis; 38(3): 145-50.
  28. Jäger R, Maurer J & Schorle H. (2003) Conditional Immortalization of Mouse Neural Crest Stem Cells. Eur J Cell Biol; Abstracts Suppl. 53, Vol.82.